Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
Hong Kong
· Delayed Price · Currency is HKD
4.990
+0.020 (0.40%)
At close: Jun 5, 2025, 4:00 PM HKT
HKG:6922 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -104.37 | -97.49 | -112.22 | -101.87 | -137.09 |
| Depreciation & Amortization | 11.84 | 9.41 | 7.62 | 4.47 | 3.15 |
| Other Amortization | 0.02 | 0.02 | 0.02 | 0.01 | - |
| Loss (Gain) From Sale of Assets | 0.01 | - | 0 | 0.11 | - |
| Asset Writedown & Restructuring Costs | 9.32 | - | - | - | -0 |
| Loss (Gain) From Sale of Investments | - | - | - | - | -0.31 |
| Stock-Based Compensation | 16.53 | 19.86 | 20.45 | 17.82 | 112.27 |
| Other Operating Activities | -6.28 | -8.75 | -8.6 | 24.73 | -23.41 |
| Change in Accounts Receivable | - | - | - | - | 2.16 |
| Change in Inventory | -5.77 | -4.71 | -8.12 | -3.62 | -1.45 |
| Change in Accounts Payable | 0.3 | -0.86 | 1.45 | 0.13 | 0.1 |
| Change in Unearned Revenue | 2.14 | -2.26 | 2.38 | -5.09 | 0.59 |
| Change in Other Net Operating Assets | -6.65 | -11.12 | 0.09 | 0.82 | 9.78 |
| Operating Cash Flow | -82.91 | -95.89 | -96.94 | -62.49 | -34.2 |
| Capital Expenditures | -1.88 | -15.1 | -7.01 | -12.44 | -1.52 |
| Sale (Purchase) of Intangibles | - | - | - | -0.06 | - |
| Investment in Securities | - | - | - | 24.93 | 27 |
| Other Investing Activities | - | - | 0.46 | 3.22 | 1.52 |
| Investing Cash Flow | -1.88 | -15.1 | -6.55 | 15.65 | 27.01 |
| Short-Term Debt Issued | 35.74 | - | - | - | - |
| Total Debt Issued | 35.74 | - | - | - | - |
| Short-Term Debt Repaid | -5.74 | - | - | - | - |
| Long-Term Debt Repaid | -4.14 | -5.45 | -2.88 | -2.26 | -0.61 |
| Total Debt Repaid | -9.89 | -5.45 | -2.88 | -2.26 | -0.61 |
| Net Debt Issued (Repaid) | 25.86 | -5.45 | -2.88 | -2.26 | -0.61 |
| Issuance of Common Stock | - | - | 187.52 | 204.38 | - |
| Other Financing Activities | -0.39 | -8.24 | -15.24 | -4.37 | - |
| Financing Cash Flow | 25.47 | -13.68 | 169.4 | 197.75 | -0.61 |
| Foreign Exchange Rate Adjustments | 1.38 | 1.66 | 2.64 | -0.53 | -0.1 |
| Net Cash Flow | -57.94 | -123.02 | 68.56 | 150.38 | -7.9 |
| Free Cash Flow | -84.79 | -111 | -103.95 | -74.93 | -35.71 |
| Free Cash Flow Margin | -158.39% | -271.05% | -382.87% | -334.11% | -394.45% |
| Free Cash Flow Per Share | -0.35 | -0.46 | -0.46 | -0.33 | - |
| Cash Interest Paid | 0.39 | - | - | - | - |
| Cash Income Tax Paid | 0.13 | - | - | - | - |
| Levered Free Cash Flow | -65.39 | -85.44 | -49.02 | -49.42 | - |
| Unlevered Free Cash Flow | -64.71 | -85.03 | -48.65 | -49.19 | - |
| Change in Net Working Capital | 9.76 | 24.36 | -10.83 | 9.69 | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.